Schedule 13G ownership disclosure
CARDIOME PHARMA CORP
Security class unavailable · CUSIP: 14159U301
Event date: 2016-08-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,423,142
- Percent of class
- 17.0100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-16-004411
- Form type
- SC 13G
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- Sep 09, 2016
- Reporting period
- Aug 31, 2016
- Description
- Schedule 13G beneficial ownership